Adult obesity increased to 28% of the US population in 2015 and the diabetes rate also climbed to 11.4%. Adults who are obese are 4.7 times more likely to be diabetic compared with adults with a normal weight
The obesity rate of US adults rose to a new high in 2015 reveals Gallup survey.
Adult obesity increased from 25.5% in 2008 to 28.0% this last year, in 2015. This left 35.6% of adults reported as overweight, 34.6% as normal weight, and 1.8% as underweight. Blacks have the highest rate of obesity at 35.6%, followed by Hispanics at 28.6%, whites at 27.0%, and Asians at 9.8%. Whites, however, have experienced the sharpest increase in obesity since 2008, undergoing a change of +2.8 percentage points.
“Overall, adults who are currently obese are about 4.7 times more likely to be diabetic compared with those who are normal weight, a probability that doesn't vary significantly for individual racial or ethnic groups,” reported Gallup.
The diabetes rate for US adults has also climbed during this past year, to 11.4%. Again, Blacks have the largest percentage of diabetes diagnoses with 14.5%. Whites come in second with 11.0%, Hispanics with 10.7%, and Asians with 5.2%.
Past research has indicated that obesity, and the chronic conditions associated therewith, cost the US economy $153 billion per annum. Individually, obesity not only affects the physical aspects of wellbeing but may affect the financial and social aspects, as well. The reverse is also true, where high wellbeing may reduce the risks of becoming obese.
States, communities, and workplaces have the ability to combat obesity by helping to develop interventions that target behaviors and factors linked to obesity including exercise habits, produce consumption, healthy eating, smoking, depression, food insecurity, unsafe exercise environments, lack of personal doctor, or poor dental hygiene.
Data was collected from the Gallup-Healthways Well-Being Index that calculated the body mass index of individuals from self-reported weight and height. The sample incorporated more than 350,000 phone interviews from 2008-2012, and over 175,000 phone interviews from 2013-2015 from adults 18 years and older living in all 50 states and DC.
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
March 14th 2025Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ranges from 4% to 28%, according to studies from the US and Europe—and that the prevalence of these comorbid condition is on the rise.
Read More